A randomized, open-label, single dose, crossover study to evaluate the pharmacokinetic characteristics and safety of KD4002 in healthy volunteers under fasting conditions
A randomized, open-label, single dose, crossover study to evaluate the pharmacokinetic characteristics and safety of KD4002 in healthy volunteers under fed conditions